Trimethylamine N-oxide Impairs Oocyte Maturation and Embryogenesis via NF-κB/NLRP3 Pathway Modulation
Findings demonstrate that TMAO disrupts oocyte development through NF- κB/NLRP3 activation, contributing to ovarian dysfunction. Notably, targeting TMAO and its downstream signaling could serve as a novel therapeutic strategy for premature ovarian insufficiency (POI).
Authors
- Yanle Guo (ORCID: https://orcid.org/0000-0003-0134-377X)
- Jiwu Lou (ORCID: https://orcid.org/0000-0001-8250-1498)
- Yong-Mei Zhang (ORCID: https://orcid.org/0000-0002-8289-2107)
- Fengping He
- Tizhen Yan
Institutions
- Shantou University (CN)
- Yue Bei People's Hospital (CN)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2025-05-26
- DOI
- https://doi.org/10.2174/0115680096364675250419135908
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00